Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. ABCO Laboratories, Inc.
483
•ABCO Laboratories, Inc.•March 10, 2020

FDA 483 - ABCO Laboratories, Inc. - March 10, 2020

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

ABCO Laboratories, Inc. in Fairfield, CA, a contract manufacturer of over-the-counter drugs, received a Form 483 with three observations. The inspection revealed deficiencies in laboratory controls, specifically the failure to perform required analytical and microbiological testing, and issues with the quality control unit's procedures, including the lack of qualification for a third-party testing laboratory. Additionally, the firm failed to conduct annual product reviews for its OTC drug products.

Company
ABCO Laboratories, Inc.
Inspection Date
March 10, 2020
Product Type
Drugs
Office
Division of Human and Animal Food Operations - West V
Person
  • John A. Gonzalez (Drug Enforcement Administration)
Open in Dashboard

ID · 15a69543-d5f2-47d7-9333-9509a2c6e832

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.